日本在线观看不卡,国产成人免费观看,国产gaysex男同视频chinese,欧美一级www

樹(shù)人論文網(wǎng)一個(gè)專(zhuān)業(yè)的學(xué)術(shù)咨詢網(wǎng)站!!!
樹(shù)人論文網(wǎng)
學(xué)術(shù)咨詢服務(wù)

EXPERT OPINION ON THERAPEUTIC PATENTS

來(lái)源: 樹(shù)人論文網(wǎng) 瀏覽次數(shù):453次
Monthly
創(chuàng)刊時(shí)間:1994
所屬分區(qū):2區(qū)
周期:Monthly
ISSN:1354-3776
影響因子:3.699
是否開(kāi)源:No
年文章量:97
錄用比:一般
學(xué)科方向:藥物化學(xué)
研究方向:醫(yī)學(xué)
通訊地址:INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON, ENGLAND, EC2A 4LQ
官網(wǎng)地址:http://www.tandfonline.com/loi/ietp20#.V48csUz9cSQ
投稿地址:https://mc.manuscriptcentral.com/eotp
網(wǎng)友分享經(jīng)驗(yàn):較慢,6-12周

EXPERT OPINION ON THERAPEUTIC PATENTS雜志中文介紹

由Informa Pharmaceutical Science出版(原名Ashley Publications)。國(guó)際標(biāo)準(zhǔn)書(shū)號(hào):1354-3776。《關(guān)于治療專(zhuān)利的專(zhuān)家意見(jiàn)》(ISSN1354-3776)每月出版一期,是醫(yī)藥專(zhuān)利信息方面的領(lǐng)先專(zhuān)利期刊。關(guān)于治療專(zhuān)利的專(zhuān)家意見(jiàn)提供了一個(gè)每月的,同行評(píng)審的指導(dǎo),以技術(shù)進(jìn)步和藥物專(zhuān)利的發(fā)展。鼓勵(lì)作者對(duì)所審查研究的現(xiàn)狀發(fā)表專(zhuān)家意見(jiàn),而不是簡(jiǎn)單地審查現(xiàn)有數(shù)據(jù)。該期刊的每一期都包含了注釋性的專(zhuān)利選擇和簡(jiǎn)短的專(zhuān)利評(píng)估,突出了相關(guān)專(zhuān)家認(rèn)為具有潛在重要性的發(fā)明和創(chuàng)新理念。觀眾包括制藥行業(yè)的科學(xué)家、管理者和決策者,以及其他與研發(fā)密切相關(guān)的人。訂戶包括美國(guó)、歐洲和日本的大多數(shù)主要制藥公司,以及許多生物技術(shù)公司。關(guān)于治療專(zhuān)利的專(zhuān)家意見(jiàn)采用了系統(tǒng)的覆蓋方法,每個(gè)問(wèn)題都集中在一個(gè)主要的治療領(lǐng)域。

EXPERT OPINION ON THERAPEUTIC PATENTS雜志英文介紹

Published by Informa Pharmaceutical Science (formerly Ashley Publications). ISSN: 1354-3776.Expert Opinion on Therapeutic Patents (EOTP) (ISSN 1354-3776) is published monthly and is the leading patent journal for pharmaceutical patent information. Expert Opinion on Therapeutic Patents provides a monthly, peer-reviewed guide to the technological advances and developments in pharmaceutical patents. Authors are encouraged to express their Expert Opinion of the status of the research under review, rather than to simply review the available data. Each issue of the journal contains annotated patent selections and short patent evaluations which highlight inventions and innovative ideas deemed by relevant experts to be of potential importance. The audience consists of scientists, managers and decision-makers in the pharmaceutical industry, and others closely involved in R&D. Subscribers include most of the major pharmaceutical companies in the USA, Europe and Japan, and many biotechnology companies. Expert Opinion on Therapeutic Patents adopts a systematic approach to coverage, with each issue focusing on one of the major therapeutic areas.

EXPERT OPINION ON THERAPEUTIC PATENTS期刊H指數(shù)

影響因子 h-index Gold OA文章占比 研究類(lèi)文章占比 OA開(kāi)放訪問(wèn) 平均審稿速度
6.714 61 1.82% 12.12% 未開(kāi)放 較慢,6-12周

EXPERT OPINION ON THERAPEUTIC PATENTS期刊JCR分區(qū)趨勢(shì)圖

EXPERT OPINION ON THERAPEUTIC PATENTS影響因子